USPTO serial 90458206
BIOFIDELITY
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Mar 29, 2022
- Examiner
- SULLIVAN, JOHN C
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with BIOFIDELITY?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Ben Natter
Ben Natter HAUG PARTNERS LLP745 Fifth AvenueNEW YORK, NY 10151UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical, biochemical and biological preparations for scientific purposes; chemical reagents; chemicals preparations for use as reagents; chemicals, reagents and chemical preparations for use in diagnostics; in vitro diagnostic preparations and reagents for scientific and research purposes; chemicals, reagents and chemical preparations for scientific purposes, namely, for use in tests and testing; kits comprising assays, chemicals, reagents and chemical preparations for scientific purposes; chemical assays for research purposes; kits for conducting molecular analysis of biological samples comprising of assays, chemicals, reagents and chemical preparations for scientific and research purposes; chemical preparations for laboratory and diagnostic use; chemical preparations for use in relation to the detection and monitoring of cancer, inherited disease, genetic predispositions and drug responses for scientific purposes; chemical preparations for use in relation to the analysis and monitoring of tumours for scientific purposes; chemicals for use in the analysis and identification of nucleic acids and nucleic acid sequences, infectious agents and pathogens; diagnostic kits comprising reagents and assays for use in relation to the analysis of DNA or RNA for scientific use; none of the foregoing being for medical or veterinary purposes | ACTIVE | — |
| 005 | Medical and veterinary preparations and substances, namely, diagnostic preparations for medical purposes; chemical, biochemical and biological preparations being reagents for medical and veterinary purposes; chemical, biochemical and biological preparations and reagents for medical clinical diagnostic purposes; medical and veterinary diagnostic preparations and reagents; in vitro diagnostic preparations for medical purposes; diagnostic preparations for clinical medical use; reagents for the treatment, monitoring or diagnosis of disease for medical purposes; reagents for clinical medical use; reagents for in-vitro laboratory use for medical purposes; medical and veterinary testing preparations, namely, reagents; chemical reagents for medical laboratory analysis; chemical reagents used for medical diagnosis and analysis; kits comprised of assays for diagnosis and testing in the medical and veterinary fields; kits for conducting molecular analysis of biological samples comprising of assays, chemicals, reagents and chemical preparations for clinical and medical purposes; diagnostic preparations for use in relation to the detection, treatment and monitoring of cancer, inherited disease, genetic predispositions, and drug responses, for medical purposes; diagnostic preparations or for use in relation to the analysis and monitoring of tumours for medical purposes; compounds and reagents for medical analysis and identification of nucleic acids and nucleic acid sequences, infectious agents and pathogens for medical purposes; diagnostic preparations for use in relation to the analysis of DNA or RNA for medical purposes; chemical preparations for use in relation to the treatment of cancer, inherited disease, genetic predispositions and drug responses | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Biofidelity Ltd
- Other trademarks owned by Biofidelity Ltd
- Other trademarks owned by Biofidelity Ltd
- Other trademarks in Class 001
- Other trademarks in Class 005
- Similar marks named BIOFIDELITY
- Prosecution event R.PR explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 29, 2022 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Feb 20, 2022 | ETOP | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED | — |
| Jan 20, 2022 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jan 20, 2022 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 20, 2022 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Nov 10, 2021 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| Oct 12, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Oct 12, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 22, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Sep 9, 2021 | FIXD | ELECTRONIC RECORD REVIEW COMPLETE | — |
| Sep 3, 2021 | ERRR | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED | — |
| Aug 31, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 31, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 31, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 30, 2021 | ALIE | ASSIGNED TO LIE | — |
| Aug 25, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 23, 2021 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 23, 2021 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 23, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 20, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 9, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jan 14, 2021 | NWAP | NEW APPLICATION ENTERED | — |